A Food and Drug Administration advisory panel recommended on Friday that compounding pharmacies be allowed to manufacture the peptide epitalon, but narrowly voted to recommend against manufacturing emideltide.[5435635] The FDA is weighing a politically charged decision on compounded peptides, with Revolution Medicines advancing a promising pancreatic cancer drug toward approval and new evidence suggesting Merck's Ebola vaccine may help blunt the DRC's Bundibugyo outbreak.[5268865] Peptides, which are short-chain amino acids, have become increasingly popular in the U.S., driven by endorsements from social media influencers.[5268865]